GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai INT Medical Instruments Co Ltd (HKSE:01501) » Definitions » Beneish M-Score

Shanghai INT Medical Instruments Co (HKSE:01501) Beneish M-Score : -2.77 (As of Jul. 15, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Shanghai INT Medical Instruments Co Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.77 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Shanghai INT Medical Instruments Co's Beneish M-Score or its related term are showing as below:

HKSE:01501' s Beneish M-Score Range Over the Past 10 Years
Min: -2.99   Med: -2   Max: -0.45
Current: -2.77

During the past 9 years, the highest Beneish M-Score of Shanghai INT Medical Instruments Co was -0.45. The lowest was -2.99. And the median was -2.00.


Shanghai INT Medical Instruments Co Beneish M-Score Historical Data

The historical data trend for Shanghai INT Medical Instruments Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai INT Medical Instruments Co Beneish M-Score Chart

Shanghai INT Medical Instruments Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only -1.09 -0.45 -2.79 -2.00 -2.77

Shanghai INT Medical Instruments Co Semi-Annual Data
Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.79 - -2.00 - -2.77

Competitive Comparison of Shanghai INT Medical Instruments Co's Beneish M-Score

For the Medical Instruments & Supplies subindustry, Shanghai INT Medical Instruments Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai INT Medical Instruments Co's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai INT Medical Instruments Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Shanghai INT Medical Instruments Co's Beneish M-Score falls into.


;
;

Shanghai INT Medical Instruments Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Shanghai INT Medical Instruments Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.8391+0.528 * 0.922+0.404 * 0.9917+0.892 * 1.1046+0.115 * 0.6256
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0606+4.679 * -0.014881-0.327 * 1.2155
=-2.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec24) TTM:Last Year (Dec23) TTM:
Total Receivables was HK$126.9 Mil.
Revenue was HK$909.6 Mil.
Gross Profit was HK$574.0 Mil.
Total Current Assets was HK$952.5 Mil.
Total Assets was HK$2,412.8 Mil.
Property, Plant and Equipment(Net PPE) was HK$884.1 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$85.3 Mil.
Selling, General, & Admin. Expense(SGA) was HK$213.8 Mil.
Total Current Liabilities was HK$463.9 Mil.
Long-Term Debt & Capital Lease Obligation was HK$16.6 Mil.
Net Income was HK$204.9 Mil.
Gross Profit was HK$0.0 Mil.
Cash Flow from Operations was HK$240.8 Mil.
Total Receivables was HK$136.9 Mil.
Revenue was HK$823.4 Mil.
Gross Profit was HK$479.2 Mil.
Total Current Assets was HK$792.2 Mil.
Total Assets was HK$2,220.0 Mil.
Property, Plant and Equipment(Net PPE) was HK$893.2 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$52.0 Mil.
Selling, General, & Admin. Expense(SGA) was HK$182.5 Mil.
Total Current Liabilities was HK$346.5 Mil.
Long-Term Debt & Capital Lease Obligation was HK$17.1 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(126.926 / 909.607) / (136.933 / 823.436)
=0.139539 / 0.166295
=0.8391

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(479.152 / 823.436) / (574.047 / 909.607)
=0.581893 / 0.631093
=0.922

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (952.505 + 884.083) / 2412.812) / (1 - (792.212 + 893.171) / 2219.962)
=0.238818 / 0.240805
=0.9917

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=909.607 / 823.436
=1.1046

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(52.014 / (52.014 + 893.171)) / (85.269 / (85.269 + 884.083))
=0.05503 / 0.087965
=0.6256

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(213.781 / 909.607) / (182.466 / 823.436)
=0.235026 / 0.221591
=1.0606

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((16.575 + 463.857) / 2412.812) / ((17.124 + 346.541) / 2219.962)
=0.199117 / 0.163816
=1.2155

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(204.901 - 0 - 240.807) / 2412.812
=-0.014881

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Shanghai INT Medical Instruments Co has a M-score of -2.77 suggests that the company is unlikely to be a manipulator.


Shanghai INT Medical Instruments Co Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Shanghai INT Medical Instruments Co's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai INT Medical Instruments Co Business Description

Traded in Other Exchanges
N/A
Address
No. 925 Jin Yuan Yi Road, Block 2, Jiading District, Shanghai, CHN, 201803
Shanghai INT Medical Instruments Co Ltd engages in the design and development of medical devices used in fields including peripheral intervention, neurological intervention, cardiovascular intervention, or implantation, and the design and development of equipment and moulds used for the production of medical devices. The company operates in the Chinese Mainland, Europe, the United States, and Other countries and regions. The majority of the revenue comes from the Chinese Mainland.
Executives
Jpmorgan Chase & Co. 2106 Person having a security interest in shares
China Orient Asset Management (international) Holding Limited 2201 Interest of corporation controlled by you
Zhao Wei 2202 Interest of your spouse
Wang Kai 2201 Interest of corporation controlled by you
Ningbo Huaige Taiyi Equity Investment Partnership (limited Partnership) 2101 Beneficial owner
Ningbo Huaige Health Investment Management Partnership (limited Partnership) 2201 Interest of corporation controlled by you
Ningbo Huaige Gongxin Equity Investment Partnership (limited Partnership) 2201 Interest of corporation controlled by you
Central Huijin Investment Ltd. 2201 Interest of corporation controlled by you
Orbimed Capital Llc 2102 Investment manager
Zhao Wei 2202 Interest of your spouse
Zheng Aiping 2501 Other
Zhang Xianmiao 2501 Other
Zhang Wei 2501 Other
Shanghai Kindly Holding Group Co., Ltd. 2201 Interest of corporation controlled by you
Worldwide Healthcare Trust Plc 2101 Beneficial owner

Shanghai INT Medical Instruments Co Headlines

No Headlines